News

Search:  

Latest News | 14 May 2012

FDA Issues New Recommendations for MS Drug After Cardiovascular Concerns Raised

0 Likes

The US Food and Drug Administration (FDA) has placed new contraindications on Novartis’ Multiple Sclerosis drug Gilenya (fingolimod) after investigating the cases of several patients who died soon [Read More...]


Latest News | 3 February 2012

Reuters: French Regulatory Authority, Executives Searched In Mediator Probe

0 Likes

The offices of French regulatory authority Afssaps were searched by French investigators on 2 February as part of an investigation in to deaths associated with Servier’s anti-diabetes drug Mediator, [Read More...]